...
首页> 外文期刊>Cancer Cell >Targeting the tumor and its microenvironment by a dual-function decoy Met receptor.
【24h】

Targeting the tumor and its microenvironment by a dual-function decoy Met receptor.

机译:通过双重功能诱饵Met受体靶向肿瘤及其微环境。

获取原文
获取原文并翻译 | 示例
           

摘要

Met, the receptor for hepatocyte growth factor (HGF), is activated in human cancer by both ligand-dependent and -independent mechanisms. We engineered a soluble Met receptor (decoy Met) that interferes with both HGF binding to Met and Met homodimerization. By lentiviral vector technology, we achieved local or systemic delivery of decoy Met in mice. We provide evidence that in vivo expression of decoy Met (1) inhibits tumor cell proliferation and survival in a variety of human xenografts, (2) impairs tumor angiogenesis by preventing host vessel arborization, (3) suppresses or prevents the formation of spontaneous metastases, and (4) synergizes with radiotherapy in inducing tumor regression, without (5) affecting housekeeping physiological functions in the adult animal.
机译:Met是肝细胞生长因子(HGF)的受体,通过配体依赖性和非依赖性机制在人类癌症中被激活。我们设计了一种可溶的Met受体(诱饵Met),该受体可干扰HGF与Met的结合以及Met的同二聚作用。通过慢病毒载体技术,我们实现了在小鼠中局部或全身递送诱饵Met。我们提供的证据表明,诱饵Met的体内表达(1)在多种人类异种移植物中抑制肿瘤细胞的增殖和存活;(2)通过阻止宿主血管的乔化损害肿瘤血管生成;(3)抑制或阻止自发转移的形成, (4)与放疗协同作用以诱导肿瘤消退,而不会(5)影响成年动物的管家生理功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号